North America Veterinary Clinical Trials Market

The North America Veterinary Clinical Trials market encompasses the services and processes required for testing the safety and efficacy of new drugs, vaccines, and biologics for animals. The primary customers are pharmaceutical and biopharmaceutical companies, alongside academic and research institutions. Key growth drivers include rising pet ownership and the humanization of pets, the growing prevalence of chronic diseases in animals, and technological innovations that improve trial efficiency.

CAGR

10%

Compound Annual Growth Rate

Current Value

$2.17B

Estimated 2026

Projected Value

$3.84B

By 2032